We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Catheter Lock Solution Keeps Bacteria at Bay

By HospiMedica staff writers
Posted on 01 Oct 2007
A citric acid based catheter lock solution (CLS) eliminates the growth of bacteria, yeast, and fungi in different types of catheters.

The Loxxit CLS--a 46.7% trisodium citrate dihydrate in a 5 mL solution--is a sterile solution that prevents the coagulation of blood, eliminates the growth of microorganisms in any type of intravenous catheter, and prevents biofilm formation through the catheter lumen. More...
Trisodium citrate dihydrate is a tribasic salt of citric acid, and is produced by complete neutralization of citric acid with high purity sodium source and subsequent crystallization. Trisodium citrate dihydrate is widely used in foods, beverages, and various technical applications mainly as a buffering, sequestering, or emulsifying agent.

Loxxit is a defined as a preventive-action product, since it is designed to prevent problems from occurring rather than treating problems that have occurred. The Loxxit solution is a product of Citra Anticoagulants (Braintree, MA, USA), and has been received the European Community (CE) mark.

Microbial biofilms formed in catheters are associated with systemic infections as well as decreased efficiency due to catheter thrombosis. Currently, the most widely used anticoagulant CLS in use is sodium heparin; the CLS functions by physically occupying space within the catheter and exerting pressure on the patient's circulating blood, preventing it from back filling into the catheter and clotting.


Related Links:
Citra Anticoagulants

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.